期刊文献+

17α-羟基黄体酮C11α-羟化菌株的筛选及工艺优化 被引量:1

Screening and Fermentation Optimization of 17α-hydroxyprogesterone C11α-hydroxylation Strain
原文传递
导出
摘要 11α,17α-二羟基黄体酮(11α,17α-dihydroxy progesterone)作为甾体激素类药物的重要中间体,其生物合成主要以17α-羟基黄体酮作为底物转化生成。为探究不同微生物对17α-羟基黄体酮的转化能力,以11株具有甾体羟化能力的菌株为研究对象,通过全细胞生物转化实验,筛选得到了一株转化能力最强的菌株亚麻刺盘孢SF-307。通过单因素实验和正交设计进行菌株发酵培养基组分优化,确定了最适发酵培养基:15 g/L可溶性淀粉、1.8 g/L氯化铵、0.6 g/L氯化镁、3 g/L玉米浆。优化培养基后的亚麻刺盘孢SF-307转化产物唯一,当底物投料量为0.5 g/L,添加1%(V/V)乙醇进行助溶,转化56 h时,底物转化率为93.2%,11α,17α-二羟基黄体酮的最高浓度为224.1 mg/L,较优化前提高61.1%。上述结果表明:亚麻刺盘孢SF-307作为一株全新的17α-羟基黄体酮羟化菌株,发酵优化可显著增强17α-羟基黄体酮转化产物的选择性,缩短转化周期,对11α,17α-二羟基黄体酮的工业生产意义重大。 11α,17α-dihydroxy progesterone is an important intermediate of steroid hormone drugs and its biosynthesis is mainly produced by microbial transformation of 17α-hydroxyprogesterone.In order to explore the transformation ability of different microorganisms to 17α-hydroxyprogesterone,11 strains with steroid hydroxylation ability were selected.Through the whole-cell biotransformation experiment,Colletotrichum lini SF-307 with the strongest transformation ability was obtained.Then,the optimal composition of the fermentation medium was determined by a single-factor experiment and orthogonal design.The most suitable fermentation medium was determined:15 g/L soluble starch,1.8 g/L ammonium chloride,0.6 g/L magnesium chloride,and 3 g/L corn pulp.After optimization,the only product 11α,17α-dihydroxy progesterone was produced by C.lini SF-307.When the substrate was fed at 0.5 g/L with the addition of 1%(V/V)ethanol for co-solubilization,the substrate conversion was 93.2%and the highest concentration was 224.1 mg/L at 56 h,which was increased by 61.1%compared to the original.The results showed that C.lini SF-307 was a new strain of 17α-hydroxyprogesterone hydroxylation.The fermentation optimization can significantly enhance selectivity of 17α-hydroxyprogesterone conversion products and shorten the transformation period.This study is of great significance to the industrial production of 11α,17α-dihydroxy progesterone.
作者 伏家强 李会 王维龙 王淑丽 武胜 邓庆博 史劲松 许正宏 FU Jia-qiang;LI Hui;WANG Wei-long;WANG Shu-li;WU Sheng;DENG Qing-bo;SHI Jin-song;XU Zheng-hong(College of Life Sciences and Health Engineering,Jiangnan University,Wuxi 214122,China;Tianjin Pharmaceutical Research Institute Limited Company,Tianjin 300301,China;Jinyao Pharmaceutical Limited Company,Tianjin 300301,China;Key Laboratory of Industrial Biotechnology of Ministry of Education,School of Bio-Engineering,Jiangnan University,Wuxi 214122,China)
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2023年第9期19-32,共14页 China Biotechnology
基金 国家重点研发计划(2019YFA0905300) 国家自然科学基金(22078126) 天津市合成生物技术创新能力提升行动(TSBICIP-KJGG-001-14)。
关键词 11α 17α-二羟基黄体酮 17α-羟基黄体酮 生物转化 亚麻刺盘孢SF-307 发酵优化 11α 17α-dihydroxy progesterone 17α-hydroxyprogesterone Biotransformation Colletotrichum lini SF-307 Fermentation optimization
  • 相关文献

参考文献8

二级参考文献65

共引文献20

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部